crisp_bio

RIKEN (NISLO, WDCM ...) - NIG (DDBJ/CIB, WDCM, OECD BRC, GBIF, JST BIRD, TPRP ...) - FREE

タグ:がん

[出典] “Immunogenicity Risk Assessment of Process-related Impurities in an Engineered T cell Receptor Cellular Product” Mora J, Forman D, Hu J et al. J Pharm Sci 2024-05-18. https://doi.org/10.1016/j.xphs.2024.05.018 [所属] Bristol Myers Squibb, ImmunXp ... もっと読む
このエントリーをはてなブックマークに追加

[出典] “NUP43 promotes PD-L1/nPD-L1/PD-L1 feedback loop via TM4SF1/JAK/STAT3 pathway in colorectal cancer progression and metastatsis” Wu F, Sun G, Nai Y, Shi X, Ma Y, Cao H. Cell Death Discov 2024-05-18. https://doi.org/10.1038/s41420-024-02025-z [所属 ... もっと読む
このエントリーをはてなブックマークに追加

[出典] REVIEW “Mesenchymal stem cell-derived extracellular vesicles: Recent therapeutics and targeted drug delivery advances” Bhat A [..] Chand S. J Extracell Biol. 2024-05-17. https://doi.org/10.1002/jex2.156 [所属] U Nebraska Medical Center, Michigan ... もっと読む
このエントリーをはてなブックマークに追加

[出典] Review “CRISPR/Cas9 screening: unraveling cancer immunotherapy’s ‘Rosetta Stone’” Chen B, Deng Y, Ren X, Zhao J, Jiang C. Trends Mol Med. 2024-05-18. https://doi.org/10.1016/j.molmed.2024.04.014 [所属] Zhongnan Hospital of Wuhan U, McGill U; ... もっと読む
このエントリーをはてなブックマークに追加

[出典] “PLAG1 interacts with GPX4 to conquer vulnerability to sorafenib induced ferroptosis through a PVT1/miR-195-5p axis-dependent manner in hepatocellular carcinoma” Li J,  Li Y, Wang D, Liao R, Wu Z. J Exp Clin Can Res 2024-05-14. https://doi.org/1 ... もっと読む
このエントリーをはてなブックマークに追加

↑このページのトップヘ